Relative survival analysis quantifies the survival of cancer patients by comparing observed survival in a patient cohort with the expected survival of a comparable segment of the general population.

According to data from 2012–2018, those with vaginal cancer have a 51% likelihood of surviving for at least 5 years from the date of their diagnosis compared with people without the disease. This is ...

Testicular cancer generally has a favorable survival rate at any stage. Due to screening guidelines and increased awareness, it’s often diagnosed early, offering a good chance for a cure. Testicular ...

Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A ...

Hayes et al., 2026, doi: 10.1111/add.70211.

Survival rates for non-small cell lung cancer (NSCLC) vary depending on the stage at diagnosis, with localized cancer having a 63% 5-year survival rate, while distant cancer that has spread to other ...

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new ...